Lanean...
Insights about the Economic impact of COPD readmissions post implementation of the Hospital Readmission Reduction Program
PURPOSE OF REVIEW: Chronic Obstructive Pulmonary Disease (COPD) affects over 12 million adults in the US and is the third leading cause of 30-day readmissions. COPD is costly with almost $50 billion in direct costs annually. Total COPD costs can be up to double the identified direct costs due to co-...
Gorde:
| Argitaratua izan da: | Curr Opin Pulm Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5810972/ https://ncbi.nlm.nih.gov/pubmed/29210750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCP.0000000000000454 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|